To know whether the treatment was associated with tumor PD-L1 status, we performed PD-L1 IHC and found that tumors were stained weakly for PD-L1 expression in all groups and the expression level was not affected by different treatments (Supplementary Fig. S2). This evidence concerns the gene CD274 and neoplasm.